COVID-19 and dentistry in 72 questions: An overview of the literature

S Derruau, J Bouchet, A Nassif, A Baudet… - Journal of Clinical …, 2021 - mdpi.com
The outbreak of Coronavirus Disease 2019 (COVID-19), caused by Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has significantly affected the dental …

Immune responses 6 months after mRNA-1273 COVID-19 vaccination and the effect of a third vaccination in patients with inborn errors of immunity

LPM Van Leeuwen, M Grobben… - Journal of clinical …, 2023 - Springer
Purpose Patients with inborn errors of immunity (IEI) are at increased risk of severe
coronavirus disease-2019 (COVID-19). Effective long-term protection against COVID-19 is …

SARS-CoV-2 vaccine responses in individuals with antibody deficiency: findings from the COV-AD study

AM Shields, SE Faustini, HJ Hill, S Al-Taei… - Journal of clinical …, 2022 - Springer
Background Vaccination prevents severe morbidity and mortality from COVID-19 in the
general population. The immunogenicity and efficacy of SARS-CoV-2 vaccines in patients …

Case series: convalescent plasma therapy for patients with COVID-19 and primary antibody deficiency

J Lang-Meli, J Fuchs, P Mathé, H Ho, L Kern… - Journal of clinical …, 2022 - Springer
Patients with primary antibody deficiency are at risk for severe and in many cases for
prolonged COVID-19. Convalescent plasma treatment of immunocompromised individuals …

Reactive T cells in convalescent COVID-19 patients with negative SARS-CoV-2 antibody serology

S Steiner, T Schwarz, VM Corman, F Sotzny… - Frontiers in …, 2021 - frontiersin.org
Despite RT-PCR confirmed COVID-19, specific antibodies to SARS-CoV-2 spike are
undetectable in serum in approximately 10% of convalescent patients after mild disease …

Antigen-Specific CD4+ T-Cell Activation in Primary Antibody Deficiency After BNT162b2 mRNA COVID-19 Vaccination

KMT Sauerwein, CB Geier, RF Stemberger… - Frontiers in …, 2022 - frontiersin.org
Previous studies on immune responses following COVID-19 vaccination in patients with
common variable immunodeficiency (CVID) were inconclusive with respect to the ability of …

SARS-CoV-2-Specific and functional cytotoxic CD8 cells in primary antibody deficiency: Natural infection and response to vaccine

S Gupta, S Agrawal, A Sandoval, H Su, M Tran… - Journal of clinical …, 2022 - Springer
Purpose CD8 cytotoxic T cells (CTLs) play a critical role in the clearance of virally infected
cells. SARS-CoV-2-specific CD8 T cells and functional CTLs in natural infections and …

Outcome of SARS-CoV-2 infection among patients with common variable immunodeficiency and a matched control group: A Danish nationwide cohort study

TL Katzenstein, LD Rasmussen, CH Drabe… - Frontiers in …, 2022 - frontiersin.org
The risk of severe adult respiratory coronavirus-2 (SARS-CoV-2) infection and the course of
the infection among individuals with common variable immunodeficiency (CVID) relative to …

Expert consensus: main risk factors for poor prognosis in COVID-19 and the implications for targeted measures against SARS-CoV-2

FJ Candel, P Barreiro, M Salavert, A Cabello… - Viruses, 2023 - mdpi.com
The clinical evolution of patients infected with the Severe Acute Respiratory Coronavirus
type 2 (SARS-CoV-2) depends on the complex interplay between viral and host factors. The …

Why do some people develop serious COVID-19 disease after infection, while others only exhibit mild symptoms?

M Ballow, CL Haga - The Journal of Allergy and Clinical Immunology: In …, 2021 - Elsevier
The year 2020 was a landmark year of a once-in-a-century pandemic of a novel coronavirus,
SARS-CoV-2 virus, that led to a rapidly spreading coronavirus disease (COVID-19). The …